IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 505-512

  Ahmed, Raef S ^a   Kim, Robert Y ^a,b   Duan, Jun ^a   Meleth, Streelatha ^a   De Los Santos, Jennifer F ^a   Fiveash, John B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervical neoplasms; Dose escalation; IMRT; Organs at risk; Para aortic lymph nodes

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; DOSIMETRY; IMAGE ANALYSIS; MAGNETIC RESONANCE; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

BONE MARROW; GROSS TARGET VOLUME (GTV); INTENSITY MODULATED RADIATION THERAPY (IMRT); PARA-AORTIC LYMPH NODE (PALN);

DRUG DOSAGE;

ARTICLE; BONE MARROW; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEASIBILITY STUDY; FEMALE; HUMAN; KIDNEY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; SPINAL CORD; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; UTERINE CERVIX CANCER;

AORTA; BONE MARROW; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 4544317781     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.035     Document Type: Article

References (32)

1. Stehman F.B., Bundy B.N., Disaia P.J., et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 67:1991;2276-2285
2. Eifel P.J., Morris M., Wharton J.T., et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;9-16
3. Hoskins W.J. Prognostic factors for risk of recurrence in stage IB and IIA cervical cancer. Baillieres Clin Obstet Gynaecol. 2:1988;817-828
4. Potish R., Adcock L., Jones T.K., et al. The morbidity and utility of a periaortic radiotherapy in cervical carcinoma. Gynecol Oncol. 15:1983;1-9
5. Piver M.S., Barlow J.J., Krishnamsetty R. Five year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol. 139:1981;575-578
6. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys. 42:1998;1015-1023
7. Grigsby P.W., Lu J.D., Mutch D.G., et al. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes Phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys. 41:1998;817-822
8. Haie C., Pejovic M.H., Gerbaulet A., et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 11:1988;101-112
9. Rotman M., Pajak T.F., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas Ten-year treatment results of RTOG 79-20. JAMA. 274:1995;387-393
10. Morris M., Eifel P.J., Lu J. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143
11. Mutic S., Malyapa R.S., Grigsby P.W., et al. Pet guided IMRT for cervical carcinoma with positive para-aortic lymph nodes - A dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys. 55:2003;28-35
12. Ellis R.E. The distribution of active bone marrow in adult. Phys Med Biol. 5:1961;255-258
13. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 51:2001;261-266
14. Mundt A.J., Mell L.K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 56:2003;1354-1360
15. Lujan A.E., Mundt A.J., Yamada S.D., et al. Intensity modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 57:2003;516-521
16. Argiris A., Maris T., Vlahos L. T2 relaxation times of irradiated vertebral bone marrow in patients with seminoma. Magn Reson Imaging. 15:1997;335-340
17. Grigsby P.W., Heydon K., Mutch D.G., et al. Long-term follow-up of RTOG 92-10 Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 51:2001;982-987
18. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 17:1999;1339-1348
19. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153
20. Peters W.A. 3rd, Liu P.Y., Barrett R.J. 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 18:2000;1606-1613
21. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161
22. U.S. Dept. of Health and Human Services. NCI Clinical announcement. Public Health Services, National Institutes of Health, Bethesda, MD, February 1999
23. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307
24. Fyles A.W., Dembo A.J., Bush R.S., et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys. 22:1992;847-851
25. Lhomme C., Fumoleau P., Fargeot P., et al. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotican in patients with advanced or recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 17:1999;3136-3142
26. Paley P.J., Goff B.A., Minudri R., et al. The prognostic significance of radiation dose and residual tumor in treatment of barrel-shaped endophytic cervical carcinoma. Gynecol Oncol. 76:2000;373-379
27. Kim R.Y., Trotti A., Wu C.J., et al. Radiation alone in the treatment of cancer of the uterine cervix Analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys. 17:1989;973-978
28. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor size, irradiation dose, and long term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys. 41:1998;307-317
29. Grigsby P.W., Siegel B.A., Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 19:2001;3745-3749
30. Rose P.G., Adler L.P., Rodriguez M. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging A surgicopathologic study. J Clin Oncol. 17:1999;41-45
31. Fajardo L.F., Berthrong M., Anderson R.E. Hematopoietic tissue. Fajardo L.F., Berthrong M., Anderson R.E. Radiation pathology. 2001;379-388 Oxford University press, Oxford
32. Brixey C.J., Roeske J.C., Lujan A.E., et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 54:2002;1388-1396